Publication Name	World Journal of Methodology
Manuscript ID	21790
Country	Spain

Received	2015-07-30 08:49
Peer-Review Started	2015-07-31 11:36
To Make the First Decision	2015-08-14 15:21
Return for Revision	2015-08-24 16:24
Revised	2015-08-27 23:07
Second Decision	2015-09-28 14:37
Accepted by Journal Editor-in-Chief	2015-09-28 16:12
Accepted by Executive Editor-in-Chief	2015-10-13 17:20
Articles in Press	2015-10-13 17:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-12-03 13:13
Publish the Manuscript Online	2015-12-15 10:10

ISSN	2222-0682 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Selecting the best strategy of treatment in newly diagnosed advanced-stage ovarian cancer patients
Manuscript Source	Invited Manuscript
All Author List	Lucas Minig, Cristina Zorrero, Pablo Padilla Iserte and Andres Poveda
Funding Agency and Grant Number
Corresponding Author	Lucas Minig, MD, PhD, MBA, Gynecology Department, Clinical Area of Gynecologic Oncology, Valencian Institue of Oncology, C/del Profesor Beltran Baguena 8, 46009 Valencia, Spain. miniglucas@gmail.com
Key Words	Ovarian cancer; Advanced stage; Primary debulking surgery; Neoadjuvant chemotherapy; Patients’ selection
Core Tip	Selecting the best strategy of treatment in newly diagnosed advanced-stage ovarian cancer patients is a multifactorial and multidisciplinary decision. Surgeries performed by gynecologic oncologists with formal training in cytoreductive techniques at referral centers are crucial factors in obtaining better oncologic outcomes. However, other factors such as clinical status of the patients, the hospital’s infrastructure and equipment, as well as the tumor biology of each individual patient should also be taken into account before deciding on an initial strategy of treatment in women with advanced-stage ovarian cancer.
Publish Date	2015-12-15 10:10
Citation	Minig L, Zorrero C, Iserte PP, Poveda A. Selecting the best strategy of treatment in newly diagnosed advanced-stage ovarian cancer patients. World J Methodol 2015; 5(4): 196-202
URL	http://www.wjgnet.com/2222-0682/full/v5/i4/196.htm
DOI	http://dx.doi.org/10.5662/wjm.v5.i4.196

Full Article (PDF)	WJM-5-196.pdf
Full Article (Word)	WJM-5-196.doc
Manuscript File	21790-Review.doc
Answering Reviewers	21790-Answering reviewers.pdf
Audio Core Tip	21790-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	21790-Conflict-of-interest statement.pdf
Copyright License Agreement	21790-Copyright assignment.pdf
Peer-review Report	21790-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	21790-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	21790-Scientific misconduct check.pdf
Scientific Editor Work List	21790-Scientific editor work list.pdf